Sat, Apr 19, 2014, 10:51 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

BroadSoft, Inc. (BSFT) Message Board

eurotyle 178 posts  |  Last Activity: Apr 18, 2014 5:32 PM Member since: Jun 30, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    SEC Form S-3

    by jaredjhess Apr 18, 2014 5:18 PM
    eurotyle eurotyle Apr 18, 2014 5:32 PM Flag

    turbulence

  • Reply to

    SEC Form S-3

    by jaredjhess Apr 18, 2014 5:18 PM
    eurotyle eurotyle Apr 18, 2014 5:31 PM Flag

    Punit's a finance guy, rest assured he will not offer shares in times of turbulent seeing he just made a 40k dollar purchase a few weeks prior.

    Rest assured he'll complete an offering when the markets are once again soaring into the year end (sept-dec) range when it's not even relevant because ONCS will be $1.50-$2.50 by then are issuing shares at that price will be welcome to shore up financials for future uplisting to NASD.

    Rest assured, a savvy finance guy at the helm knows how to play his cards right.

    Just my humble opinion of course. Overall I agree with Furbush's sentiment of Q4.

    Sentiment: Buy

  • Reply to

    ONCS moving forward

    by jhankster60 Apr 18, 2014 7:07 AM
    eurotyle eurotyle Apr 18, 2014 1:07 PM Flag

    Paul, Ahhh, now I know what I recognize your scree name, probably from AudioCodes. I loaded the boat with AUDC shares (total of 20k shares) with an average purchase price of $3.60-$3.70. That was a fun ride upward, quite rapidly indeed. Must love Josh Franklin at SA for the extra support as well.

    I got freaked out on surely a day you remember (the Israel tension) when AUDC got blasted for 10-15% in one day. I sold everything that day around the $5.90-$6.000 handle.

    Sure I missed the big ride upwards afterwards to $9 and change, but it didn't personally matter here. I had my $45,000 wedding coming up in October 2013 and the funds were superb to nearly have a free wedding from a few months of holding AUDC.

    AUDC is still heading to $17-$22 in a matter of a couple years whilst SONS will be $8-$10 in the same time-frame. These guys are a win-win.

    Good to see you on the ONCS board Paul!

    Sentiment: Buy

  • Reply to

    50DMA at .71 cents

    by eurotyle Apr 17, 2014 3:44 PM
    eurotyle eurotyle Apr 17, 2014 4:24 PM Flag

    Most definitely. I didn't have the %$&#@$ to add in the .40's or low .50's, but at least I had the opportunity to add at .59 and again at .61.

    Have a great Easter weekend everyone.

  • Reply to

    50DMA at .71 cents

    by eurotyle Apr 17, 2014 3:44 PM
    eurotyle eurotyle Apr 17, 2014 4:13 PM Flag

    Only 7

  • Reply to

    50DMA at .71 cents

    by eurotyle Apr 17, 2014 3:44 PM
    eurotyle eurotyle Apr 17, 2014 4:13 PM Flag

    I follow 182 biotech/medical companies cast over 3 Yahoo portfolios. Only 87 are above their 50DMA, ONCS being one of them.

  • Reply to

    50DMA at .71 cents

    by eurotyle Apr 17, 2014 3:44 PM
    eurotyle eurotyle Apr 17, 2014 4:12 PM Flag

    Could be - All depending on where the wind (market sails) take us or internally if there is any relevant positive news.

    Simply stating that it's great to be a penny above the 50 DMA while most other biotechs are struggling trending below or slightly above their 200 DMA's.

    Majority (a solid 96-97% that I personally follow) of biotechs are not even anywhere close to their 50 DMA's.

  • Reply to

    50DMA at .71 cents

    by eurotyle Apr 17, 2014 3:44 PM
    eurotyle eurotyle Apr 17, 2014 3:52 PM Flag

    Here we are at .71. A close of .71 or above would be an OUTSTANDING sign.

  • Reply to

    50DMA at .71 cents

    by eurotyle Apr 17, 2014 3:44 PM
    eurotyle eurotyle Apr 17, 2014 3:44 PM Flag

    Nice to close I meant.

  • eurotyle by eurotyle Apr 17, 2014 3:44 PM Flag

    Would be to close at or above the 50 day moving average today.

    Surely would be a bullish-reversal sign.

    Sentiment: Buy

  • eurotyle eurotyle Apr 17, 2014 4:21 AM Flag

    While they may be talented, they are far from the Robert Duggan's (PCYC), Dr. Bergers (ARIA), Alan Auerbach (Cougar Bio (Sold to J&J) - Puma (PBYI) or Alfred Mann's of the world.

    They are still an unproven bunch, unlike some of the elite names mentioned above.

    Fourthly, as far as electroporation goes, this methodology is honestly quite painful. The delivery method of the electrical pulses are excruciating painful to say the least. If you think your 110v home outlets give you a shock, you're in for a surprise with electroporation my friend. At the current time (unless changed), there's no chance the FDA would approve such a delivery method in it's current form (borderline stop-your-heart and place you in cardiac arrest mode) for treatment of anything. Clearly, Oncosec, like a few others are working on ways to rework this method of delivery. We haven't quite figured out how to reduce the voltage from our home's electrical system yet, but best of luck designing a new machine to fulfill this functionality. If successfully done, they might want to look into home automation and electrical services as an operating subsidiary.

    Finally (for a good chuckle), after watching Dr. Daud's video on the electroporation delivery system, doesn't the OncoSec machine in the background mildly resemble the same machine Will Smith was attempting to sell in the Pursuit of Happyness? I always wondered after watching that movie if these machines were still around or not....I guess they are available after all, simply re-badged since they are most like outsourced and made in China now amongst most everything else.

    Once again, I'm bullish here, but the road ahead is full on landmines, so please tread carefully. Never fall in love with an equity and always remember, you never will lose money selling for a gain.

    I'm simply giving you my honest opinion and feedback in these two winded posts. Appreciate some feedback and constructive criticism. Both sides (buyers/sellers) welcome.

  • Furbush -

    Very true BB, we all invest differently, have different goals, risk tolerance, and time. On top of your thoughts of accelerated approval, ONCS starts into breast cancer even a completion of P1 with good results will add tremendous market cap to this company. A P1 trial should take less than 3 months, so EOY price could easily reach $5, definitely be over $2.

    My Response -

    That's what the shareholders of GALE thought too.

    Don't jump the gun before buying the bullets. It's the market, nothing is promised and anything can happen. Only invest what you're willing to lose and never bet the house.

    GO ONCS!

    Brother's Response -

    Sorry euro but that is a terrible analogy. GALE's rise and crash was due to false pumping, ONCS is severely undervalued, has three potential AA trials and will be starting multiple new Phase 1s this year, one of which may be Breast Cancer. Furbush's predictions are perfectly sensible and well within current projections.

    My Resonse -

    See two messages posted below. Feedback is undeniably welcome.

  • Reply to

    Remember a long time is a relative term

    by brotherbear44 Apr 16, 2014 2:01 PM
    eurotyle eurotyle Apr 17, 2014 4:13 AM Flag

    While they may be talented, they are far from the Robert Duggan's (PCYC), Dr. Bergers (ARIA), Alan Auerbach (Cougar Bio (Sold to J&J) - Puma (PBYI) or Alfred Mann's of the world.

    They are still an unproven bunch, unlike some of the elite names mentioned above.

    Fourthly, as far as electroporation goes, this methodology is honestly quite painful. The delivery method of the electrical pulses are excruciating painful to say the least. If you think your 110v home outlets give you a shock, you're in for a surprise with electroporation my friend. At the current time (unless changed), there's no chance the FDA would approve such a delivery method in it's current form (borderline stop-your-heart and place you in cardiac arrest mode) for treatment of anything. Clearly, Oncosec, like a few others are working on ways to rework this method of delivery. We haven't quite figured out how to reduce the voltage from our home's electrical system yet, but best of luck designing a new machine to fulfill this functionality. If successfully done, they might want to look into home automation and electrical services as an operating subsidiary.

    Finally (for a good chuckle), after watching Dr. Daud's video on the electroporation delivery system, doesn't the OncoSec machine in the background mildly resemble the same machine Will Smith was attempting to sell in the Pursuit of Happyness? I always wondered after watching that movie if these machines were still around or not....I guess they are available after all, simply re-badged since they are most like outsourced and made in China now amongst most everything else.

    Once again, I'm bullish here, but the road ahead is full on landmines, so please tread carefully. Never fall in love with an equity and always remember, you never will lose money selling for a gain.

    I'm simply giving you my honest opinion and feedback in these two winded posts. Appreciate some feedback and constructive criticism. Both sides (buyers/sellers) welcome.

    Sentiment: Buy

  • Reply to

    Remember a long time is a relative term

    by brotherbear44 Apr 16, 2014 2:01 PM
    eurotyle eurotyle Apr 17, 2014 4:00 AM Flag

    Brother -

    Appreciate your insight (and everyone else's on this board for that matter). I know your uber-bullish, maybe even a permabull on OncoSec being a financially sound investment and company one day. This day may come, however as of yet, we're simply a biotechnology-development company (one with seemingly bright and intelligent people and a very interesting way of potentially treating cancer).

    I don't wish to cause drama on rain on your permabull parade, however this is biotechnology brother, anything can happen. Surely we might do well (clinicals/breakthrough indications/partnerships/FDA approvals/etc), but don't forget the negative side as well (we could also go bust, relatively easy at that).

    I'm a shareholder here holding a relatively sizable position (not like Punit's position or anything, but a decent investment nonetheless). Clearly, I would want the most success and highest stock price for ONCS, that's undisputed.

    As a self-employed and successful realist though, I tend to see that there are plenty of negatives to also go around (in addition to all the positives you speak daily of).

    First off, electroporation in it's entirety of existence is still an unproven treatment methodology (hence why probably most of us are here, early investors).

    Secondly, whilst it's surely an exciting time to be in the immunooncology or electro-oncology business, it's still full of landmines and boatloads of failures relative to success stories. To be frank, the only immunooncology product to have success thus far was Provenge by Dendreon. I'm not sure if you would consider Dendreon a success story anymore, however let the facts fall where they may.

    Thirdly, the management team seems on the right path with a mixture of younger entrepreneurial talent and older medical minds. Granted the CMO of ONCS has experience in the field due to his previous career with Merck, they are still relative unknowns in this world. No track record and no drugs brought to market.

    Sentiment: Buy

  • eurotyle eurotyle Apr 17, 2014 12:15 AM Flag

    I would say we would raise funds in 2015 since we have enough cash to last in 2016.

    By then, I would be certain some large pharma/biotech at least bets $25-$100 million into ONCS with royalty agreements anywhere from $100 million to $1 Billion if trials rock, approvals come, etc etc.

    Surely worth the risk at 65 cents.

    Sentiment: Buy

  • eurotyle eurotyle Apr 16, 2014 11:01 PM Flag

    Punit said 24-25 million with a burn rate of about 2-2.25m per quarter to be precise (Needham conference). He said he was content with the cash position (someone in the crowd specifically asked about financials even though it was conveyed via his speech).

    Sentiment: Buy

  • Reply to

    Got lucky

    by thefretgenie Apr 16, 2014 10:40 AM
    eurotyle eurotyle Apr 16, 2014 5:34 PM Flag

    Good outlook Steve. Hopefully ONCS makes Karen and yourself proud one day.

  • Reply to

    Remember a long time is a relative term

    by brotherbear44 Apr 16, 2014 2:01 PM
    eurotyle eurotyle Apr 16, 2014 3:26 PM Flag

    That's what the shareholders of GALE thought too.

    Don't jump the gun before buying the bullets. It's the market, nothing is promised and anything can happen. Only invest what you're willing to lose and never bet the house.

    GO ONCS!

    Sentiment: Buy

  • Reply to

    Remember a long time is a relative term

    by brotherbear44 Apr 16, 2014 2:01 PM
    eurotyle eurotyle Apr 16, 2014 3:22 PM Flag

    We're at .65 now.

  • eurotyle eurotyle Apr 16, 2014 12:23 PM Flag

    I added another 9000, bringing down my weighted average cost.

BSFT
25.65+0.82(+3.30%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.